相似文献
1
Responsiveness differences in outcome instruments after revision hip arthroplasty: what are the implications?翻修髋关节置换术后结局评估工具的反应性差异：这意味着什么？
BMC Musculoskelet Disord. 2011 May 23;12:107. doi: 10.1186/1471-2474-12-107.
2
Responsiveness and minimal important differences after revision total hip arthroplasty.翻修全髋关节置换术后的反应性和最小有意义差异。
BMC Musculoskelet Disord. 2010 Nov 12;11:261. doi: 10.1186/1471-2474-11-261.
3
Validation of the HOOS, JR: A Short-form Hip Replacement Survey.《髋关节置换术患者报告结局量表简表（HOOS，JR）的验证》
Clin Orthop Relat Res. 2016 Jun;474(6):1472-82. doi: 10.1007/s11999-016-4718-2. Epub 2016 Feb 29.
4
Is total hip arthroplasty after hip arthrodesis as good as primary arthroplasty?髋关节融合术后全髋关节置换术与初次关节置换术一样好吗？
Clin Orthop Relat Res. 2011 Jul;469(7):1971-83. doi: 10.1007/s11999-010-1704-y. Epub 2010 Nov 30.
5
Clinically important improvement thresholds for Harris Hip Score and its ability to predict revision risk after primary total hip arthroplasty.Harris髋关节评分的临床重要改善阈值及其预测初次全髋关节置换术后翻修风险的能力。
BMC Musculoskelet Disord. 2016 Jun 10;17:256. doi: 10.1186/s12891-016-1106-8.
6
What Is the Survivorship of Revision Surgery Performed for the Chronically Dislocated THA?翻修手术治疗慢性髋关节置换术后脱位的存活率如何？
Clin Orthop Relat Res. 2019 Feb;477(2):374-379. doi: 10.1097/CORR.0000000000000392.
7
Function and activity after minimally invasive total hip arthroplasty compared to a healthy population.与健康人群相比，微创全髋关节置换术后的功能与活动情况。
Int Orthop. 2018 Feb;42(2):297-302. doi: 10.1007/s00264-017-3541-z. Epub 2017 Jul 12.
8
Two-stage total hip arthroplasty: how often does it control methicillin-resistant infection?两阶段全髋关节置换术：它能控制耐甲氧西林金黄色葡萄球菌感染的频率有多高？
Clin Orthop Relat Res. 2011 Apr;469(4):1009-15. doi: 10.1007/s11999-010-1725-6.
9
Function and survival after revision of hip resurfacing.髋关节表面置换翻修后的功能与生存率
Hip Int. 2011 Sep-Oct;21(5):610-5. doi: 10.5301/HIP.2011.8679.
10
Standard Comorbidity Measures Do Not Predict Patient-reported Outcomes 1 Year After Total Hip Arthroplasty.标准合并症测量方法无法预测全髋关节置换术后1年患者报告的结局。
Clin Orthop Relat Res. 2015 Nov;473(11):3370-9. doi: 10.1007/s11999-015-4195-z.
本文引用的文献
1
Responsiveness and minimal important differences after revision total hip arthroplasty.翻修全髋关节置换术后的反应性和最小有意义差异。
BMC Musculoskelet Disord. 2010 Nov 12;11:261. doi: 10.1186/1471-2474-11-261.
2
3
Challenges with health-related quality of life assessment in arthroplasty patients: problems and solutions.关节置换术后患者健康相关生活质量评估的挑战：问题与解决方案。
J Am Acad Orthop Surg. 2010 Feb;18(2):72-82.
4
Variation in outcome measures in hip and knee arthroplasty clinical trials: a proposed approach to achieving consensus.髋关节和膝关节置换临床试验中结局指标的差异：达成共识的一种建议方法。
J Rheumatol. 2009 Sep;36(9):2050-6. doi: 10.3899/jrheum090356.
5
A power primer.强力底漆。
Psychol Bull. 1992 Jul;112(1):155-9. doi: 10.1037//0033-2909.112.1.155.
6
Can patients help with long-term total knee arthroplasty surveillance? Comparison of the American Knee Society Score self-report and surgeon assessment.患者能否助力长期全膝关节置换术监测？美国膝关节协会评分自我报告与外科医生评估的比较。
Rheumatology (Oxford). 2009 Feb;48(2):160-4. doi: 10.1093/rheumatology/ken439. Epub 2008 Dec 23.
7
Findings of extensive variation in the types of outcome measures used in hip and knee replacement clinical trials: a systematic review.髋关节和膝关节置换临床试验中使用的结局指标类型存在广泛差异的研究结果：一项系统评价
Arthritis Rheum. 2008 Jun 15;59(6):876-83. doi: 10.1002/art.23706.
8
Comparison of the responsiveness of the SF-36 and WOMAC in patients undergoing total hip arthroplasty.全髋关节置换术患者中SF-36量表与WOMAC量表反应性的比较。
J Arthroplasty. 2007 Dec;22(8):1168-73. doi: 10.1016/j.arth.2006.10.006.
9
Responsiveness and clinically important differences for the WOMAC and SF-36 after total knee replacement.全膝关节置换术后WOMAC和SF - 36量表的反应性及临床重要差异
Osteoarthritis Cartilage. 2007 Mar;15(3):273-80. doi: 10.1016/j.joca.2006.09.001. Epub 2006 Oct 17.
10
Responsiveness and clinically important differences for the WOMAC and SF-36 after hip joint replacement.髋关节置换术后WOMAC和SF-36量表的反应性及临床重要差异
Osteoarthritis Cartilage. 2005 Dec;13(12):1076-83. doi: 10.1016/j.joca.2005.06.012. Epub 2005 Sep 9.
Zotero 插件